JANUS HENDERSON GROUP PLC
SEC CIK 1274173 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 10% | 2.06M | $699.1K | — | 1 | 2024-07-24 | 2024-07-24 |
Most active insiders at ORKA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | — | $300.01M |
| 2 | Dambkowski Carl | Dir | — | $8.65M |
| 3 | Klein Lawrence Otto | CEO, Dir | — | $7.31M |
| 4 | Quinlan Paul T | GC | — | $6.76M |
| 5 | Goncalves Joana | Chief Medical Off | — | $4.54M |
| 6 | Agarwal Arjun | SVP, Fin | — | $4.33M |
| 7 | Sandler Laura Lee | COO | — | $1.94M |
| 8 | Edwards Larry Todd | Chief Commercial Off | — | — |
JANUS HENDERSON GROUP PLC made no open-market trades at ORKA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-07-26 | 2024-07-24+ | ORKA | Oruka Therapeutics, Inc. | JANUS HENDERSON GROUP PLC | 10% | P - Purchase | $3.18 | +220.1K | 2.06M | +12% | +$699.1K |
Purchase Sale Sale after option exercise All abbreviations